AstraZeneca signs pay-for-performance contracts with Harvard Pilgrim

Following the lead of pharmaceutical companies such as Novartis, Eli Lilly and Co. and Amgen, AstraZeneca signed outcomes-based contracts with Harvard Pilgrim Health Care for two of its drugs—the blood thinner Brilinta (ticagrelor), and injectable type 2 diabetes drug Bydureon (exenatide extended-release). Brilinta is used to lower the likelihood of...

Read more

CMS takes steps to change HealthCare.gov enrollment, provides checklist for state ACA waivers, issues final rule to delay bundled payment models

While the Senate contemplates what to do about the American Health Care Act (AHCA) passed by the House earlier this month, the Centers for Medicare and Medicaid Services (CMS) took steps last week that could further undermine the Affordable Care Act (ACA). On Monday, CMS proposed changes for businesses that...

Read more

Steward Health Care merger will create largest private for-profit hospital operator in US

On Friday, Boston-based Steward Health Care announced a definitive agreement to merge with Franklin, Tenn.-based IASIS Healthcare LLC. If the proposed transaction is successful, the combined entity will have 36 hospitals in 10 states, approximately 38,000 employees, a network of 5,600 physicians and projected revenue of nearly $8 billion in...

Read more